Title: Hoeflich KP, et al. Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition. Cancer Res. 2012 Jan 1;72(1):210-9.
1369665-02-0
934665-56-2
934663-52-2
874758-58-4 | Ecteinascidin-Analog-1 | AA00GU5L | MFCD28385838
923126-67-4 | 2-(4-PHENYL-1,3-THIAZOL-2-YL)ACETOHYDRAZIDE | AA00GU9P | MFCD08444394
882233-17-2 | 1-(2-CHLORO-BENZYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID | AA00GUDH | MFCD04610250
887267-08-5 | 3-Fluoro-4-methyl-5-hydroxybenzoic acid | AA00GUK1 | MFCD07772031
871266-80-7 | (7-Chlorothiazolo[5,4-d]pyrimidin-2-yl)-p-tolyl-amine | AA00GUSN | MFCD08437191
93496-85-6 | Methyl 3,3,3-trifluoro-dl-lactate | AA00GV4Z | MFCD02093316
91337-45-0 | 1-Butyl-1H-benzo[d]imidazol-2-amine | AA00GVDD | MFCD00159973
938458-88-9 | 1-AMINO-PIPERIDINE-3-CARBOXYLIC ACID ETHYL ESTER | AA00GVI9 | MFCD09055216
933852-41-6 | 2-(4,5-dimethyl-3-thienyl)ethanamine | AA00GVMF | MFCD11053951
936940-12-4 | 1-(1,3,5-Trimethyl-1h-pyrazol-4-yl)ethanamine | AA00GVQX | MFCD05864525